Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Curr Opin Virol. 2011 Sep;1(3):204-10. doi: 10.1016/j.coviro.2011.05.007.
Effective preventive measures against HIV must function near the time of virus transmission to prevent the establishment of a chronic infection. Low-dose SIV/SHIV infections by multiple routes lead to remarkably rapid systemic dissemination of virus and large numbers of infected cells during the initial weeks of the acute infection. Here we describe the narrow time-frame during which potent post-exposure interventions such as anti-retroviral therapy or the administration of high-titered neutralizing antibodies can block the establishment of the in vivo infection. This short window of opportunity is applicable to HIV infections and represents a formidable challenge for developing effective chemoprophylaxis and vaccine approaches.
有效的 HIV 预防措施必须在病毒传播时发挥作用,以防止慢性感染的建立。通过多种途径进行低剂量的 SIV/SHIV 感染会导致病毒在急性感染的最初几周内迅速全身扩散,并产生大量感染细胞。在这里,我们描述了在这段时间内,高效的暴露后干预措施(如抗逆转录病毒治疗或高滴度中和抗体的给予)可以阻止体内感染的建立。这个短暂的机会窗口适用于 HIV 感染,这对开发有效的化学预防和疫苗方法构成了巨大挑战。